Chongqing Xishan Science and Technology Co (SHSE:688576) Cash-to-Debt : 755.13 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Chongqing Xishan Science and Technology Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Chongqing Xishan Science and Technology Co's cash to debt ratio for the quarter that ended in Mar. 2024 was 755.13.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Chongqing Xishan Science and Technology Co could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Chongqing Xishan Science and Technology Co's Cash-to-Debt or its related term are showing as below:

SHSE:688576' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.31 Med: 53.97 Max: 755.13
Current: 755.13

During the past 7 years, Chongqing Xishan Science and Technology Co's highest Cash to Debt Ratio was 755.13. The lowest was 0.31. And the median was 53.97.

SHSE:688576's Cash-to-Debt is ranked better than
92.65% of 857 companies
in the Medical Devices & Instruments industry
Industry Median: 1.9 vs SHSE:688576: 755.13

Chongqing Xishan Science and Technology Co Cash-to-Debt Historical Data

The historical data trend for Chongqing Xishan Science and Technology Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Chongqing Xishan Science and Technology Co Cash-to-Debt Chart

Chongqing Xishan Science and Technology Co Annual Data

Trend

Dec13

Dec14

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.31

10.30

32.26

53.97

512.73

Chongqing Xishan Science and Technology Co Quarterly Data
	Dec13	Dec14	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial										60.01	453.20	615.05	512.73	755.13

Competitive Comparison of Chongqing Xishan Science and Technology Co's Cash-to-Debt

For the Medical Instruments & Supplies subindustry, Chongqing Xishan Science and Technology Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Xishan Science and Technology Co's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chongqing Xishan Science and Technology Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Chongqing Xishan Science and Technology Co's Cash-to-Debt falls into.

Chongqing Xishan Science and Technology Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Chongqing Xishan Science and Technology Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1586.374	/	(3.006	+	0.088)
	=	512.73

Chongqing Xishan Science and Technology Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1443.812	/	(1.846	+	0.066)
	=	755.13

Chongqing Xishan Science and Technology Co (SHSE:688576) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Chongqing Xishan Science and Technology Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Chongqing Xishan Science and Technology Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Xishan Science and Technology Co (SHSE:688576) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chongqing Xishan Science and Technology Co Ltd (SHSE:688576) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121

Website

https://www.xishantech.com.cn

Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.

Chongqing Xishan Science and Technology Co (SHSE:688576) Headlines

No Headlines